Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing therapies for solid tumors and serious diseases. Its lead investigational product, certepetide, activates the C-end rule active transport mechanism to enhance delivery of co-administered anti-cancer drugs into solid tumors. Certepetide is being studied in Phase 2 trials for mPDAC, cholangiocarcinoma, appendiceal cancer, colon cancer, and glioblastoma multiforme, in combination with chemotherapy and immunotherapy regimens.
expected 2026-12-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0000320017-26-000023 | EDGAR | 80K words |
| 2025-02-27 | 2024-12-31 | 0000320017-25-000011 | EDGAR | 73K words |
| 2024-02-29 | 2023-12-31 | 0000320017-24-000007 | EDGAR | 72K words |
| 2023-03-30 | 2022-12-31 | 0000320017-23-000011 | EDGAR | 76K words |
| 2022-03-22 | 2021-12-31 | 0000320017-22-000016 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0000320017-21-000043 | EDGAR | — |
| 2020-03-05 | 2019-12-31 | 0000320017-20-000016 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0000320017-19-000024 | EDGAR | — |
| 2018-03-22 | 2017-12-31 | 0000320017-18-000021 | EDGAR | — |
| 2017-03-17 | 2016-12-31 | 0000320017-17-000008 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0000320017-26-000038 | EDGAR | 21K words |
| 2025-11-06 | 2025-09-30 | 0000320017-25-000070 | EDGAR | 21K words |
| 2025-08-07 | 2025-06-30 | 0000320017-25-000060 | EDGAR | 21K words |
| 2025-05-08 | 2025-03-31 | 0000320017-25-000030 | EDGAR | 17K words |
| 2024-11-12 | 2024-09-30 | 0000320017-24-000058 | EDGAR | 16K words |
| 2024-08-12 | 2024-06-30 | 0000320017-24-000051 | EDGAR | 16K words |
| 2024-05-09 | 2024-03-31 | 0000320017-24-000031 | EDGAR | 15K words |
| 2023-11-02 | 2023-09-30 | 0000320017-23-000063 | EDGAR | 22K words |
| 2023-08-14 | 2023-06-30 | 0000320017-23-000055 | EDGAR | 23K words |
| 2023-05-09 | 2023-03-31 | 0000320017-23-000028 | EDGAR | 22K words |
| 2022-11-10 | 2022-09-30 | 0000320017-22-000102 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000320017-22-000057 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-17 | 0001140361-26-036866 | EDGAR | 5K words |
| 2026-08-04 | 0001140361-26-031028 | EDGAR | 1K words |
| 2026-07-24 | 0001140361-26-029541 | EDGAR | 1K words |
| 2026-07-17 | 0001140361-26-028763 | EDGAR | 1K words |
| 2026-04-03 | 0001140361-26-013070 | EDGAR | 2K words |
| 2026-03-09 | 0000320017-26-000020 | EDGAR | 2K words |
| 2026-02-27 | 0000320017-26-000012 | EDGAR | 1K words |
| 2026-01-27 | 0000320017-26-000008 | EDGAR | 1K words |
| 2026-01-21 | 0000320017-26-000006 | EDGAR | 2K words |
| 2025-11-06 | 0000320017-25-000069 | EDGAR | 3K words |
345 total filings indexed. 313 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000320017 |
| Ticker | LSTA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Basking Ridge, NJ |
| Website | https://www.lisata.com |
| Listed | 1999-03-01 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/LSTA (~200 tokens, structured JSON with cryptographic provenance)